Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

DESLORELIN-INDUCED DELAY OF PUBERTY INCREASES ADULT HEIGHT OF ADOLESCENTS WITH SHORT STATURE: RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED TRIAL. 592

Luteinizing hormone-releasing hormone agonist (LHRHa) treatment improves adult height in children with LHRH-dependent precocious puberty. To determine whether LHRHa can enhance adult height in patients with short stature and normally timed puberty, we enrolled 50 children in a randomized, double blind, placebo-controlled trial of placebo or LHRHa (deslorelin 4 μg/kg/d sq) for 4 yr (actual mean ± SD LHRHa duration 3.6 ± 0.7 yr; for placebo, 2.4 ± 1.5 yr). 37 patients (7 males in each group) have achieved near-final adult height (bone age ≥ 16y, growth velocity < 1.5 cm/yr). Of the remaining 13 patients, 2 are lost to followup and 11 are still growing.Table

Table 1

We conclude that a 3.6-year period of deslorelin-induced pubertal delay increases adult height by 6 cm (range 1.1-12.7 cm) in adolescents with a normally timed puberty and extreme short stature.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yanovski, J., Rose, S., Filmer, K. et al. DESLORELIN-INDUCED DELAY OF PUBERTY INCREASES ADULT HEIGHT OF ADOLESCENTS WITH SHORT STATURE: RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED TRIAL. 592. Pediatr Res 39, 101 (1996). https://doi.org/10.1203/00006450-199604001-00613

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1203/00006450-199604001-00613

Search

Quick links